Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
A. T. Ali & F. Guidozzi. (2020) Midlife women’s health consequences associated with polycystic ovary syndrome. Climacteric 23:2, pages 116-122.
Read now
Read now
Nafiye Helvaci & Bulent Okan Yildiz. (2020) Cardiovascular health and menopause in aging women with polycystic ovary syndrome. Expert Review of Endocrinology & Metabolism 15:1, pages 29-39.
Read now
Read now
Articles from other publishers (37)
Pirbhat Shams, Intisar Ahmed & Zainab Samad. 2024. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
136
140
.
Yulith Roca Alvarez, Madison Pico, Namrita Ashokprabhu, Kareem Abou-Amro, Samantha Bailey, Elizabeth Pung, Evan Oberholster & Odayme Quesada. (2023) Polycystic Ovarian Syndrome: a Risk Factor for Cardiovascular Disease. Current Atherosclerosis Reports.
Crossref
Crossref
Mardia López-Alarcón, Víctor Saúl Vital-Reyes, Eduardo Almeida-Gutiérrez, Jorge Maldonado-Hernández, Salvador Flores-Chávez, Juan Manuel Domínguez-Salgado, José Vite-Bautista, David Cruz-Martínez, Aly S. Barradas-Vázquez & Ricardo Z’Cruz-López. (2023) Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications. Journal of Personalized Medicine 13:9, pages 1319.
Crossref
Crossref
Hendrikus J.A. van OsJos P. KanningMichel D. FerrariTobias N. BontenJanet M. KistHedwig M.M. VosRimke C. VosHein PutterRolf H.H. GroenwoldMarieke J.H. Wermer. (2023) Added Predictive Value of Female-Specific Factors and Psychosocial Factors for the Risk of Stroke in Women Under 50. Neurology 101:8.
Crossref
Crossref
Alok Kumar Dwivedi, Deepanjali Vishwakarma, Pallavi Dubey & Sireesha Reddy. (2023) Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States. European Journal of Endocrinology 188:6, pages 555-563.
Crossref
Crossref
Salim A Al Busaidi, Muzna Al-Farsi, Juhaina S Al-Maqbali, Masoud Salim Kashoob, Hatem Farhan, Bader Al Rawahi & Abdullah M Al Alawi. (2023) Extensive Arterial and Venous Thrombosis in a Female With a Known Untreated Polycystic Ovarian Syndrome: A Case Report. Cureus.
Crossref
Crossref
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Raja Ganesan, Abhijit Dey, Achsha Babu, Kaviyarasi Renu, Balachandar Vellingiri, Gnanasambandan Ramanathan, George Priya Doss C., Nehal Elsherbiny, Amira M. Elsherbini, Alsamman M. Alsamman, Hatem Zayed & Abilash Valsala Gopalakrishnan. (2023) The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review. Metabolites 13:1, pages 129.
Crossref
Crossref
Salman Zahid, Muhammad Zia Khan, Smitha Gowda, Nadeen N. Faza, Michael C. Honigberg, Arthur (Jason) Vaught, Carolyn Guan, Anum S. Minhas & Erin D. Michos. (2022) Trends, Predictors, and Outcomes of Cardiovascular Complications Associated With Polycystic Ovary Syndrome During Delivery Hospitalizations: A National Inpatient Sample Analysis (2002–2019). Journal of the American Heart Association 11:16.
Crossref
Crossref
Banafsheh Yalameha, Hamid Reza Nejabati & Mohammad Nouri. (2022) Circulating microparticles as indicators of cardiometabolic risk in PCOS. Clinica Chimica Acta 533, pages 63-70.
Crossref
Crossref
Kehinde S. Olaniyi & Stephanie E. Areloegbe. (2022) Suppression of PCSK9/NF-kB-dependent pathways by acetate ameliorates cardiac inflammation in a rat model of polycystic ovarian syndrome. Life Sciences 300, pages 120560.
Crossref
Crossref
Olatokunbo Osibogun, Oluseye OgunmorotiOlamide B. KoladeAllison G. HaysVictor OkunrintemiAnum S. MinhasMartha GulatiErin D. Michos. (2022) A Systematic Review and Meta-Analysis of the Association Between Polycystic Ovary Syndrome and Coronary Artery Calcification. Journal of Women's Health 31:6, pages 762-771.
Crossref
Crossref
Sai Lahari Sangaraju, Daniela Yepez, Xavier A Grandes, Ramya Talanki Manjunatha & Salma Habib. (2022) Cardio-Metabolic Disease and Polycystic Ovarian Syndrome (PCOS): A Narrative Review. Cureus.
Crossref
Crossref
Congying Wang, Wei Wu, Haiyan Yang, Zhenhong Ye, Yue Zhao, Jun Liu & Liangshan Mu. (2022) Mendelian randomization analyses for PCOS: evidence, opportunities, and challenges. Trends in Genetics 38:5, pages 468-482.
Crossref
Crossref
Carolyn Guan, Salman Zahid, Anum S. Minhas, Pamela Ouyang, Arthur Vaught, Valerie L. Baker & Erin D. Michos. (2022) Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease. Fertility and Sterility 117:5, pages 924-935.
Crossref
Crossref
Anna C. O’KellyErin D. Michos, Chrisandra L. ShufeltJane V. VermuntMargo B. MinissianOdayme QuesadaGraeme N. Smith, Janet W. Rich-Edwards, Vesna D. Garovic, Samar R. El Khoudary & Michael C. Honigberg. (2022) Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women. Circulation Research 130:4, pages 652-672.
Crossref
Crossref
Raksha Rani, Younis Ahmad Hajam, Rajesh Kumar, Rouf Ahmad Bhat, Seema Rai & Manzoor Ahmad Rather. (2022) A landscape analysis of the potential role of polyphenols for the treatment of Polycystic Ovarian Syndrome (PCOS). Phytomedicine Plus 2:1, pages 100161.
Crossref
Crossref
Ya.Z. Zaidieva & V.D. Kazantseva. (2022) Polycystic ovary syndrome in middle-aged women: associated diseases. Rossiiskii vestnik akushera-ginekologa 22:1, pages 45.
Crossref
Crossref
Lowri A. Allen, Natasha Shrikrishnapalasuriyar & Dafydd Aled Rees. (2021) Long‐term health outcomes in young women with polycystic ovary syndrome: A narrative review. Clinical Endocrinology.
Crossref
Crossref
Thomas R Berni, Christopher L Morgan & D Aled Rees. (2021) Women With Polycystic Ovary Syndrome Have an Increased Risk of Major Cardiovascular Events: a Population Study. The Journal of Clinical Endocrinology & Metabolism 106:9, pages e3369-e3380.
Crossref
Crossref
Birgit Vogel, Monica Acevedo, Yolande Appelman, C Noel Bairey Merz, Alaide Chieffo, Gemma A Figtree, Mayra Guerrero, Vijay Kunadian, Carolyn S P Lam, Angela H E M Maas, Anastasia S Mihailidou, Agnieszka Olszanecka, Jeanne E Poole, Clara Saldarriaga, Jacqueline Saw, Liesl Zühlke & Roxana Mehran. (2021) The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. The Lancet 397:10292, pages 2385-2438.
Crossref
Crossref
Licy L. Yanes Cardozo, Alexandra M. Huffman, Jacob E. Pruett & Damian G. Romero. 2021. Reproductive Hormones. Reproductive Hormones.
Seda Hanife Oguz & Bulent Okan Yildiz. (2021) An Update on Contraception in Polycystic Ovary Syndrome. Endocrinology and Metabolism 36:2, pages 296-311.
Crossref
Crossref
NANETTE L. ROLLENE, JESSICA A. LENTSCHER, ASHLEIGH M. HEMPHILL & ALAN H. DECHERNEY. (2021) Polycystic Ovary Syndrome and Medical Conditions. Clinical Obstetrics & Gynecology 64:1, pages 110-118.
Crossref
Crossref
Laura G. Cooney & Anuja Dokras. (2021) Cardiometabolic Risk in Polycystic Ovary Syndrome. Endocrinology and Metabolism Clinics of North America 50:1, pages 83-95.
Crossref
Crossref
Tiantian Zhu, Jinrui Cui & Mark O. Goodarzi. (2021) Polycystic Ovary Syndrome and Risk of Type 2 Diabetes, Coronary Heart Disease, and Stroke. Diabetes 70:2, pages 627-637.
Crossref
Crossref
Garima Sharma, Anum Minhas & Erin D. Michos. 2021. Sex Differences in Cardiac Diseases. Sex Differences in Cardiac Diseases
33
54
.
Jun Zhang, Ji-Hong Xu, Qian-Qin Qu & Guo-Qing Zhong. (2020) Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies. Frontiers in Cardiovascular Medicine 7.
Crossref
Crossref
Kelvin Okoth, Joht Singh Chandan, Tom Marshall, Shakila Thangaratinam, G Neil Thomas, Krishnarajah Nirantharakumar & Nicola J Adderley. (2020) Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review. BMJ, pages m3502.
Crossref
Crossref
Melanie Cree-Green. (2020) Editoral commentary: Understanding cardiovascular disease risk in women with polycystic ovary syndrome. Trends in Cardiovascular Medicine 30:7, pages 405-406.
Crossref
Crossref
Olatokunbo Osibogun, Oluseye Ogunmoroti & Erin D. Michos. (2020) Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention. Trends in Cardiovascular Medicine 30:7, pages 399-404.
Crossref
Crossref
Yi-Xin Wang, Mariel Arvizu, Janet W Rich-Edwards, Jennifer J Stuart, JoAnn E Manson, Stacey A Missmer, An Pan & Jorge E Chavarro. (2020) Menstrual cycle regularity and length across the reproductive lifespan and risk of premature mortality: prospective cohort study. BMJ, pages m3464.
Crossref
Crossref
Courtney E. Stewart & Farida Sohrabji. (2020) Gonadal hormones and stroke risk: PCOS as a case study. Frontiers in Neuroendocrinology 58, pages 100853.
Crossref
Crossref
Tsung-Hsien Lee, Cheng-Hsuan Wu, Ming-Li Chen, Hei-Tung Yip, Chun-I Lee, Maw-Sheng Lee & James Cheng-Chung Wei. (2020) Risk of Psoriasis in Patients with Polycystic Ovary Syndrome: A National Population-Based Cohort Study. Journal of Clinical Medicine 9:6, pages 1947.
Crossref
Crossref
Natalie C. Stentz, Nathanael Koelper, Kurt T. Barnhart, Mary D. Sammel & Suneeta Senapati. (2020) Infertility and mortality. American Journal of Obstetrics and Gynecology 222:3, pages 251.e1-251.e10.
Crossref
Crossref
Djuro Macut, Violeta Mladenović, Jelica Bjekić-Macut, Sarantis Livadas, Olivera Stanojlović, Dragan Hrnčić, Aleksandra Rašić-Marković, Danijela Vojnović Milutinović & Zoran Andrić. (2020) Hypertension in Polycystic Ovary Syndrome: Novel Insights. Current Hypertension Reviews 16:1, pages 55-60.
Crossref
Crossref
Dorte Glintborg, Katrine Hass Rubin, Mads Nybo, Bo Abrahamsen & Marianne Andersen. (2018) Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome. Cardiovascular Diabetology 17:1.
Crossref
Crossref
Marianne Andersen & Dorte Glintborg. (2018) Diagnosis and follow-up of type 2 diabetes in women with PCOS: a role for OGTT?. European Journal of Endocrinology 179:3, pages D1-D14.
Crossref
Crossref